JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
Newtek Business Services Corp. Prices Public Offering of 2,000,000 Shares of Common Stock
-
Janney Announces Hiring of New Research Analyst Covering Biotechnology
-
Predictive Marketing Leader EverString Announces High-Profile Additions to Its Advisory Board
-
JMP Securities Upgrades Morgan Stanley (MS) to Market Outperform
-
Anaplan Launches Marketing Apps To Deliver Efficiency And Effectiveness In Marketing
-
Newtek Business Services (NEWT) Announces 2M Share Common Stock Offering
-
Newtek Business Services Corp. Announces Public Offering of Common Stock
-
NovoCure Limited Announces Closing of Initial Public Offering
-
PlacementTracker Publishes Third Quarter 2015 PIPE Market League Tables
-
JMP Securities Resumes Neovasc (NVCN) at Market Outperform
-
Edge Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Over-Allotment Option
-
NovoCure Limited (NVCR) IPO Opens Lower
-
JMP Securities Starts State National Companies (SNC) at Market Outperform
-
JMP Securities Starts Carbylan Therapeutics (CBYL) at Market Outperform
-
NovoCure (NVCR) Launches 12.5M Common Stock IPO
-
NovoCure Limited Announces Launch of Initial Public Offering
-
NovoCure (NVCR) Trims IPO Expectations
-
Edge Therapeutics (EDGE) IPO Opens Modestly Higher
-
Chris Schulz Joins Invoca as Senior Vice President of Customer Success
-
Edge Therapeutics (EDGE) IPO Prices at $11, Well Below Expected Range
-
Medgenics (MDGN) Prices ~6.16M Common Stock Offering at $6.50/Share
-
Medgenics Prices Public Offering of Common Stock
-
Intrexon Establishes First Collaboration with Dedicated Fund
-
Edge Therapeutics Announces Pricing of Its Initial Public Offering
-
Medgenics (MDGN) Plans Common Stock Offering
-
Medgenics Announces Public Offering of Common Stock
-
Medgenics Announces Public Offering of Common Stock
-
JMP Securities Starts On Deck Capital (ONDK) at Market Perform
-
JMP Securities Downgrades OvaScience (OVAS) to Market Perform
-
Invoca Named to JMP Securities Hot 100 List of Best Privately Held Software Companies
-
Notable Analyst Rating Changes 9/29: (MU) (BMY) (RJET) Upgraded; (SCCO) (VSTM) (SQNM) Downgraded
-
JMP Securities Downgrades Verastem (VSTM) to Market Perform
-
Revionics’ Sixth Annual Customer Forum to Focus on Responsive Merchandising Models Enablement
-
Penn Medicine Immunotherapy Pioneer Carl June, MD, To Deliver Keynote On CAR-T Therapy For Hematologic Malignancies at IO360° Conference February 2016 in New York City
-
JMP Securities Starts Atara Biotherapeutics (ATRA) at Market Outperform
-
JMP Securities Upgrades Intel (INTC) to Market Perform
-
Paylocity Holding (PCTY) Prices 3.74M Common Shares at $29.75
-
Paylocity Announces Pricing of Secondary Offering
-
Paylocity Announces Pricing of Secondary Offering
-
Paylocity Holding (PCTY) Announces 3.74M Share Secondary Common Stock Offering
-
Paylocity Announces Launch of Proposed Secondary Offering
-
Paylocity Announces Launch of Proposed Secondary Offering
-
Demandbase Named to JMP Securities Hot 100 List of Best Privately Held Software Companies
-
Robert F. Carey Appointed to the Board of Directors of Argos Therapeutics
-
Robert F. Carey Appointed to the Board of Directors of Argos Therapeutics
-
Susquehanna Growth Equity (SGE) Increases Investment in High-Growth Recruiting Software Provider iCIMS
-
Strongbridge Biopharma plc Announces Launch of Its Proposed Initial U.S. Public Offering
-
Strongbridge Biopharma (SBBP) Sees IPO Offering Size of 4.25M Shares
-
NovoCure Limited Announces Launch of Initial Public Offering
-
Revionics Presents “Smart Pricing in an Omni-Channel World” at ECR Tag 2015

